Secretary of Homeland Security Jeh Johnson recently announced the appointment of Gerald W. Parker, D.V.M., Ph.D., along with 27 other new members, to the Homeland Security Science and Technology Advisory Committee (HSSTAC). The HSSTAC provides scientific and technical advice on matters related to the expansion of technological capabilities across the homeland security enterprise.
Texas A&M dedicates national pandemic influenza vaccine manufacturing facility, on track for 2016 start-up phase
Texas Governor Rick Perry, Texas A&M University System Chancellor John Sharp, Texas A&M Health Science Center CEO Brett Giroir, M.D., and officials from the U.S. Department of Health and Human Services (HHS), State of Texas and biopharmaceutical company GSK today dedicated a national pandemic influenza vaccine manufacturing facility in Bryan, Texas, which when complete will serve as an anchor for the Texas A&M Biocorridor.
While much attention has been focused on the Ebola outbreak that has claimed over 2,000 lives across West Africa, there are other, more easily spread infectious diseases lurking – like pandemic influenza virus. Gerald Parker, D.V.M., Ph.D., vice president for public health preparedness and response at the Texas A&M Health Science Center, speaks about pandemic influenza, its implications for society, and actions the public health community can take to mitigate damage and save lives.
Dr. Gerald Parker, vice president for public health preparedness and response, offers a roadmap for managing the next Ebola, or any global public health threat, whether naturally occurring or a deliberate attack.
Q&A: Ebola spreads in Africa, an in-depth look at the outbreak and future of emergency response planning
As the current Ebola outbreak spreads from one country in West Africa to the next, the epidemic is raising awareness of the vital role that public health and emergency response play in such scenarios, and the need for future planning to mitigate similar threats.
Vaccines are among the greatest achievements in the history of public health. However, past challenges with vaccine development processes and frequent shortages during times of need have highlighted the importance of more extensive and reliable manufacturing operations.
Dr. Gerald Parker, veterinarian, scientist, Aggie, U.S. Army veteran and former deputy assistant secretary of defense, has added a new notch to his belt: vice president for public health preparedness and response at Texas A&M Health Science Center (TAMHSC).